Julia E Maxson

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 13

Top Topics

Recombinant Human

Acute Myeloid Leukemia

Top Venues

Molecular cancer research : MCR

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

William M Yashar, Brittany M Curtiss, Daniel J Coleman, Jake VanCampen, Garth L Kong, Jommel Macaraeg, Joseph Estabrook, Emek Demir, Nicola Long, Daniel Bottomly, Shannon K McWeeney, Jeffrey W Tyner, Brian J Druker, Julia E Maxson, Theodore P Braun
Disruption of the MYC Super-Enhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia. Molecular cancer research : MCR (2023)
Sarah A Carratt, Garth L Kong, Cody Coblentz, Zachary Schonrock, Lauren Maloney, Benjamin R Weeder, William M Yashar, Rowan Callahan, Hunter Z Blaylock, Colin Coleman, Dan Coleman, Theodore P Braun, Julia E Maxson
RUNX1::ETO translocations must precede CSF3R mutations to promote acute myeloid leukemia development. Leukemia (2023)
Theodore P Braun, Joseph Estabrook, Zachary Schonrock, Brittany M Curtiss, Lucie Darmusey, Jommel Macaraeg, Trevor Enright, Cody Coblentz, Rowan Callahan, William M Yashar, Akram Taherinasab, Hisham Mohammed, Daniel J Coleman, Brian J Druker, Emek Demir, Theresa A Lusardi, Julia E Maxson
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors. Leukemia 37 (2) (2022)
Theodore P Braun, Joseph Estabrook, Zachary Schonrock, Brittany M Curtiss, Lucie Darmusey, Jommel Macaraeg, Trevor Enright, Cody Coblentz, Rowan Callahan, William M Yashar, Akram Taherinasab, Hisham Mohammed, Daniel J Coleman, Brian J Druker, Emek Demir, Theresa A Lusardi, Julia E Maxson
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors. Leukemia (2022)
Theodore P Braun, Joseph Estabrook, Zachary Schonrock, Brittany M Curtiss, Lucie Darmusey, Jommel Macaraeg, Trevor Enright, Cody Coblentz, Rowan Callahan, William M Yashar, Akram Taherinasab, Hisham Mohammed, Daniel J Coleman, Brian J Druker, Emek Demir, Theresa A Lusardi, Julia E Maxson
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors. Leukemia 37 (2) (2022)
Theodore P Braun, Joseph Estabrook, Zachary Schonrock, Brittany M Curtiss, Lucie Darmusey, Jommel Macaraeg, Trevor Enright, Cody Coblentz, Rowan Callahan, William M Yashar, Akram Taherinasab, Hisham Mohammed, Daniel J Coleman, Brian J Druker, Emek Demir, Theresa A Lusardi, Julia E Maxson
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors. Leukemia 37 (2) (2022)
Theodore P Braun, Joseph Estabrook, Zachary Schonrock, Brittany M Curtiss, Lucie Darmusey, Jommel Macaraeg, Trevor Enright, Cody Coblentz, Rowan Callahan, William M Yashar, Akram Taherinasab, Hisham Mohammed, Daniel J Coleman, Brian J Druker, Emek Demir, Theresa A Lusardi, Julia E Maxson
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors. Leukemia 37 (2) (2022)
Sarah A Carratt, Theodore P Braun, Cody Coblentz, Zachary Schonrock, Rowan Callahan, Brittany M Curtiss, Lauren Maloney, Amy C Foley, Julia E Maxson
Correction to: Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia. Leukemia (2022)
Brittany M Curtiss, Jake VanCampen, Jommel Macaraeg, Garth L Kong, Akram Taherinasab, Mitsuhiro Tsuchiya, William M Yashar, Yiu H Tsang, Wesley Horton, Daniel J Coleman, Joseph Estabrook, Theresa A Lusardi, Gordon B Mills, Brian J Druker, Julia E Maxson, Theodore P Braun
PU.1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia. Leukemia 36 (7) (2022)
Theodore P Braun, Joseph Estabrook, Zachary Schonrock, Brittany M Curtiss, Lucie Darmusey, Jommel Macaraeg, Trevor Enright, Cody Coblentz, Rowan Callahan, William M Yashar, Akram Taherinasab, Hisham Mohammed, Daniel J Coleman, Brian J Druker, Emek Demir, Theresa A Lusardi, Julia E Maxson
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors. Leukemia 37 (2) (2022)
Theodore P Braun, Joseph Estabrook, Zachary Schonrock, Brittany M Curtiss, Lucie Darmusey, Jommel Macaraeg, Trevor Enright, Cody Coblentz, Rowan Callahan, William M Yashar, Akram Taherinasab, Hisham Mohammed, Daniel J Coleman, Brian J Druker, Emek Demir, Theresa A Lusardi, Julia E Maxson
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors. Leukemia 37 (2) (2022)
Tsz-Yin Chan, Christina M Egbert, Julia E Maxson, Adam Siddiqui, Logan J Larsen, Kristina Kohler, Eranga Roshan Balasooriya, Katie L Pennington, Tsz-Ming Tsang, Madison Frey, Erik J Soderblom, Huimin Geng, Markus Müschen, Tetyana V Forostyan, Savannah Free, Gaelle Mercenne, Courtney J Banks, Jonard Corpuz Valdoz, Clifford J Whatcott, Jason M Foulks, David J Bearss, Thomas O'Hare, David Ching Siang Huang, Kenneth A Christensen, James D Moody, Steven L Warner, Jeffrey W Tyner, Joshua L Andersen
TNK1 is a ubiquitin-binding and 14-3-3-regulated kinase that can be targeted to block tumor growth. Nature communications 12 (1) (2021)
Sarah A Carratt, Theodore P Braun, Cody Coblentz, Zachary Schonrock, Rowan Callahan, Brittany M Curtiss, Lauren Maloney, Amy C Foley, Julia E Maxson
Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia. Leukemia 35 (12) (2021)